Prediction: New Reason Lilly Stock Could Still Rise
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Discover why indices rise or fall, examining earnings, macro data, and policy factors that shape broad market direction.
21,263 articlesEli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Aave Labs unveiled a multi-layered security framework for its V4 release, backed by a $1.5 million audit program. The...
Mortgage lenders are moving AI from experimentation to enterprise deployment in 2026. Addy AI's Michael Vandi explain...
Tesla is signaling a bold move beyond traditional EVs. This article examines tesla stock's bold strategic shift, what...
New fiscal data show that the cost of servicing the national debt is on track to exceed Medicare spending this year, ...
Kazakhstan's central bank unveiled a plan to allocate up to $350 million to crypto-related assets, signaling cautious...
High-income retirees who wait until age 70 to claim Social Security may face a hidden tax bill, Medicare surcharges, ...
In a volatile market, a straightforward approach is gaining traction: carve out an income sleeve that pays a steady $...
XRP faces a pivotal test as a new AI-driven forecast hints at a multi-dollar rally by the end of 2026, even as the to...
Geopolitical tensions are lifting oil prices and sending oil stocks higher. But is this trend sustainable or a tempor...
As market volatility persists in mid-2026, five high-quality dividend stocks appear especially compelling for income ...
With bond yields getting slashed, income-minded investors are turning to dividend stocks that blend steady payouts wi...